Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

1.0K
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
1.0K
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K
Clinical Trials01:16

Clinical Trials

11.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.2K
Preclinical Development: Overview01:28

Preclinical Development: Overview

6.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Zwitterionic poly(carboxybetaine) hydrogels for glucose biosensors in complex media.

Biosensors & bioelectronics·2010
Same author

Topoisomerases and site-specific recombinases: similarities in structure and mechanism.

Critical reviews in biochemistry and molecular biology·2010
Same author

Identifying patients with atypical ductal hyperplasia diagnosed at core-needle biopsy who are at low risk of malignancy.

Radiology·2010
Same author

Development and validation of an UPLC-DAD-MS method for the determination of leonurine in Chinese motherwort (Leonurus japonicus).

Journal of chromatographic science·2010
Same author

Effects of Ca2+ and Mg2+ on defluoridation in the electrocoagulation process.

Environmental science & technology·2010
Same author

Binding of different histone marks differentially regulates the activity and specificity of polycomb repressive complex 2 (PRC2).

Proceedings of the National Academy of Sciences of the United States of America·2010

Related Experiment Videos

Clinical pathways in China - an evaluation.

Jingwei Alex He1, Wei Yang

  • 1Department of Asian and Policy Studies, The Hong Kong Institute of Education, Hong Kong.

International Journal of Health Care Quality Assurance
|May 19, 2015
PubMed
Summary
This summary is machine-generated.

Clinical pathways in China did not fully achieve goals of reducing hospital stay and costs due to systemic issues. Perverse incentives and lack of staff motivation present significant barriers to effective implementation.

Keywords:
Care qualityChinaClinical pathwaysCost containment

Related Experiment Videos

Area of Science:

  • Healthcare Management
  • Health Policy
  • Clinical Practice

Background:

  • Clinical pathways (CPs) were implemented in China in 2009 to improve healthcare quality and efficiency.
  • Tertiary hospitals aimed to standardize care, reduce risks, enhance resource efficiency, and control costs through CPs.

Purpose of the Study:

  • To evaluate the impact of a clinical pathway pilot on length of stay and hospitalization costs.
  • To present a case study from a Chinese public tertiary hospital (2010-2012).

Main Methods:

  • A mixed-methods approach was employed.
  • Data were collected from hospital records and through in-depth interviews with hospital staff.

Main Results:

  • The primary objectives of standardizing treatment, reducing length of stay, and containing costs were not fully met.
  • Barriers included managerial focus on revenue over pathway utility and physician disincentives due to income concerns.

Conclusions:

  • The study highlights challenges posed by misaligned incentives within China's health system.
  • Significant health policy reforms are necessary for successful CP implementation.